Pipline

SBT-300

SBT-300


SBT Pipeline

Development Stage

Therapeutic Target(s) Route of Administration Indications Research Preclinical IND
SBT-300 KRAS & STAT3 Topical Non-Melonoma Skin Cancers (BCCA & SBCA), Actinic Keratosis